Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. HERON THERAPEUTICS, INC.
CRL
•HERON THERAPEUTICS, INC.

HERON THERAPEUTICS, INC. – FDA CRL

Record Details

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Heron Therapeutics, Inc. regarding its New Drug Application (NDA 211988) for Zynrelef (bupivacaine and meloxicam) Solution. The application, initially submitted on October 30, 2018, cannot be approved in its current form due to several nonclinical deficiencies.

The main issues center on insufficient data to adequately support the safety profile of excipients and a product specification. For triacetin, the FDA requires data to demonstrate a lack of systemic exposure following wound instillation or new reproductive and developmental toxicology studies. Similarly, for DMSO, Heron must provide a scientific bridge to show that previously referenced oral studies adequately cover exposures from the proposed drug product, or conduct appropriate new studies. The application also lacked data to qualify a proposed drug product specification, necessitating either a local tissue toxicity study at the maximum specified level or a reduction in the specification. Furthermore, for maleic acid, justification is needed to demonstrate that an oral embryofetal development study provides adequate exposure coverage for the instillation route.

To resolve these issues, Heron Therapeutics must provide additional nonclinical data or conduct new studies as outlined. Upon resubmission, a comprehensive safety update, including all new nonclinical and clinical safety data, adverse event summaries, and worldwide experience, is required. The proposed proprietary name, Zynrelef, must also be resubmitted.

Company
HERON THERAPEUTICS, INC.
Product type
Drugs
Office
Office of Neuroscience
Person
  • Kimberly J. Manhard
View Company Profile

ID · 6788d404-38c7-4b87-8b7b-a43e802729b4

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore HERON THERAPEUTICS, INC.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.